Clinical Trial Update: A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of the investigational asset ARO-INHBE in adults with obesity, with and without type 2 diabetes mellitus, is in Phase 1/Phase 2 and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ARO-INHBE

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Obesity | Phase 1, Phase 2 | Status: RECRUITING